Loading data...
Loading data...
Analyzing the stock…
70
Gathering technical, fundamental, and market data — a few seconds
Information Technology · ·
$298.46
▲ $1.20 (+0.4%)
Market data updated: 09/17 03:23 AM
Fundamentals updated: 09/17/2026
News analyzed: 09/17/2026
Market Cap
$26.95B
Day Range
$294.68 - $301.83
52-Week Range
$208.86 - $312.48
Beta
—
Next Earnings
21.10.2026
VRSN is a stock from the Technology sector — Software, hardware, chip, and computing-services companies — revenue tied to the pace of innovation and upgrade cycles.
+3.8% (1Y)
Strengths: 15/28 factors positiveRisk: High
This score and all analysis on this page are for informational and educational purposes only and do not constitute investment advice. Read the full disclaimer
Weighted: Technical 25% · Fundamental 20% · Growth 15% · Valuation 15% · News 10% · Quality 10% · Risk 5%
Overall Score
🟡 Mixed
Technical Trend
🟢 Bullish
Insiders
🔴 Bearish
Computed directly from the same signals behind the score above — not AI-generated.
Biggest positive driver
Free cash flow growth
Free cash flow growth: 22.2%
Growth
Biggest negative driver
DCF Fair Value
Estimated fair value: $190.79 vs. price $298.46 (-36.1%)
Fair Value
Signal tension
Growth scores strong (62/100), but fair-value analysis scores this stock as relatively expensive (38/100) — the growth story and the current price aren't fully aligned.
What to watch next
When today echoes the past.
NO RELIABLE ECHO FOUND
Only 2 historical analog(s) found after removing overlapping dates — too few for a statistically meaningful comparison.
Historical matches considered: 2
TIME ECHO identifies historical situations that resemble the current market state. Historical outcomes are not guarantees of future performance. Similarity does not imply causation, and results may change as new data becomes available.
🗓️ What Changed This Week
🌱 Building History
We don't have a real data point from a week ago for this stock yet. The weekly comparison will appear once enough history has accumulated.
📊 Score History
65
Today
—
30D
—
90D
—
1Y
🐂🐻 Investment Thesis
🐂 Bull Case
🐻 Bear Case
🔍 What Could Prove This Wrong
This isn't a price-direction forecast — just a synthesis of real, already-computed data, and future conditions that could change the picture.
🧬 STOCK DNA
This stock's profile across 8 real dimensions — a research tool, not a recommendation
Growth
62
Quality
58
Value
38
Momentum
80
Risk
34
Sentiment
100
Fundamental
61
Institutional
16
Stocks with a similar DNA right now
SCANNING VRSN...
Recent media coverage of Verisign has focused on its positive analyst sentiment and growth potential. Analysts, including Wedbush’s Ygal Arounian, have maintained an "Outperform" rating while raising Verisign’s price target to $341, citing multiple catalysts for above-average growth into 2027. Despite underperforming the broader market over the past year, Wall Street remains moderately optimistic about the company’s future prospects.
AI summary based on English-language news sources only — not investment advice.
Everyone's writing about Verisign. News trend score: 100. Reason: 14 of the last 20 articles are positive, versus 0 negative.
News trend analysis is based on article sentiment only, and is not investment advice or financial counsel. Read the full disclaimer
🌡️ Emotional Temperature
36
🎯 Conviction (vs. Emotion)
40
Psychology
70
Fundamentals
61
Technical
80
Valuation
38
The price is holding at a real, documented historical support/resistance level (a 50-day high or low).
The price rise has far outpaced the actual improvement in fundamental data.
Extreme momentum, price far above its moving average, and a large premium over fair value.
Price, volume, and sentiment accelerating together — a sign investors are chasing the price, not just following it.
A sharp drop, unusual volume, and negative news sentiment all at once — selling pressure that looks emotional.
Price (3M)
+13%
Market Narrative
79
Fundamental Reality
40
Narrative Gap
+39
🔀 Psychology Acceleration
News attention/sentiment is running well ahead of the price move itself.
🧠 StockIQ Psychologist
VRSN’s psychology suggests a dominant *Overconfidence* bias, where traders may overvalue momentum relative to fundamentals and discount risks due to extreme valuation (+48% above DCF). The *Euphoria* score (33) and *FOMO* indicators (momentum, sentiment) imply traders are chasing gains, while the *narrative gap* (85 vs. 40) hints at a disconnect between hype and fundamentals. The key question: will traders sustain overconfidence despite the valuation premium, or will anchoring near resistance (3.7%) trigger profit-taking? Herding remains muted today, suggesting selective participation rather than broad enthusiasm.
Updated: 09/08/2026, 07:22 PM
What could change this?
👥 What the crowd believes
"Wedbush raises price target on VeriSign to $341 from $324, Keeps Outperform Rating"
"Wall Street remains moderately optimistic about the stock’s outlook"
📈 5D Investor Psychology
Signal classification confidence: High (confidence in the behavioral read, not a price prediction). Describes observable market behavior, not what any individual investor thinks, and is not a buy/sell signal.
🏛️ Investor DNA — Historical Investors
A Historical Strategy Simulation: assuming each investor follows their documented principles, how would they rate this stock today? This is not a prediction of what they would actually do.
🟢 Best match
Morgan Housel — 72/100
🔴 Weakest match
Benjamin Graham — 0/100
🗣️ Why do they disagree?
This stock splits historical methodologies into two starkly opposing camps: the long-term, growth-oriented investors who see potential and the risk-averse, valuation-focused strategists who raise major red flags. Smith, Housel, and Fisher—all drawn to durable competitive advantages and patient holding—score it highly, framing it as a quiet compounder or a ‘buy-and-hold’ candidate, while Fisher alone notes it lacks *exceptional* quality. Meanwhile, Graham and his defensive framework flatly dismiss it, calling it a complete misfit for even his most aggressive ‘enterprising’ criteria, while Loeb, Marks, and Nelson flag it as a speculative risk or late-cycle bubble. The divide isn’t just about optimism vs. pessimism—it’s about whether the stock’s growth narrative (backed by Smith and Housel) outweighs its valuation and liquidity risks (a concern for Bagehot, Schwager, and the efficient-market camp). Even the middle-ground thinkers like Veblen and Lynch hedge, suggesting the growth may not translate to profits or that the price already discounts future gains.
Morgan Housel
The Psychology of Money (2020)
🟢 72
The kind of quiet compounder a patient holder could actually stick with
Key question
Could I live with this volatility long enough for compounding to actually work?
Fact → Principle → Simulation
Edgar Lawrence Smith
Common Stocks as Long-Term Investments (1924)
🟢 69
Looks like a real 'buy and hold for a decade' candidate
Key question
Is this a stock I'd be happy to hold and forget about for a decade?
Fact → Principle → Simulation
Philip Fisher
Common Stocks and Uncommon Profits (1958)
🟢 68
Solid, but not the exceptional quality Fisher looked for
Key question
How exceptional is this business, really?
Fact → Principle → Simulation
Jesse Livermore
Reminiscences of a Stock Operator (1923) / How to Trade in Stocks (1940)
🟡 52
No clear trend — Livermore preferred to stay out of this
Key question
What is the price telling me right now?
Fact → Principle → Simulation
Peter Lynch
One Up on Wall Street (1989)
🟡 50
Mixed — growth exists but the price already reflects much of it
Key question
Is the growth worth the price?
⚠️ Partial data for this stock — score is less reliable — Data availability: 30%
Fact → Principle → Simulation
Burton Malkiel & John Bogle
A Random Walk Down Wall Street (1973) / The Little Book of Common Sense Investing (2007)
🟡 47
Mixed case — the evidence for picking this stock over an index is not strong
Key question
Do I actually have an edge here, or do I just think I do?
Fact → Principle → Simulation
Thorstein Veblen
The Theory of Business Enterprise (1904)
🟡 45
Mixed signal on whether growth translates to real profit
Key question
Is management building real value, or just building itself?
Fact → Principle → Simulation
Charles Mackay
Extraordinary Popular Delusions and the Madness of Crowds (1841)
🟡 43
Pattern consistent with a crowd delusion Mackay would flag
Key question
Am I being swept along with the crowd, or thinking for myself?
Fact → Principle → Simulation
Gerald M. Loeb
The Battle for Investment Survival (1935)
🔴 34
Risk profile Loeb would flag as a real threat to capital
Key question
How much capital could I lose here if I'm wrong?
Fact → Principle → Simulation
Howard Marks (Market Cycle)
Mastering the Market Cycle (2018)
🔴 30
Looks late-cycle — the position Marks would treat with extra caution
Key question
Where are we in the cycle right now — near a hot extreme, or a cold one?
Fact → Principle → Simulation
Walter Bagehot
Lombard Street (1873)
🔴 27
Liquidity position Bagehot would flag as a real risk
Key question
Does this company have enough liquidity to survive real stress?
Fact → Principle → Simulation
Howard Marks
The Most Important Thing (2011) / Mastering the Market Cycle (2018)
🔴 23
Risk/valuation combination Marks would flag as a caution sign
Key question
What is the market probably misunderstanding about the risk here?
Fact → Principle → Simulation
Jack Schwager
Market Wizards (1989)
🔴 19
No real setup here — the discipline Schwager's wizards shared would say stay out
Key question
What's the risk/reward here, and where is my exit point?
Fact → Principle → Simulation
Samuel Armstrong Nelson
The ABC of Stock Speculation (1903)
🔴 13
Cycle looks stretched toward overbought
Key question
Is the price overextended, or is there still room to move?
Fact → Principle → Simulation
Benjamin Graham
Security Analysis (1934) / The Intelligent Investor (1949)
🔴 0
Fails most of Graham's defensive criteria
Key question
Where is my margin of safety?
⚠️ Partial data for this stock — score is less reliable — Data availability: 40%
Fact → Principle → Simulation
Benjamin Graham (Enterprising Investor)
The Intelligent Investor (1949) — the Enterprising Investor chapters
🔴 0
Not enough valuation data for a real Enterprising-Graham read
Key question
Is the stock statistically cheap enough to justify the extra risk?
⚠️ Partial data for this stock — score is less reliable — Data availability: 20%
Fact → Principle → Simulation
Based on the last 278 trading days, calculated from real price data. Click an indicator for details and a chart.
🟢 Most indicators support an uptrend (8 bullish · 2 bearish · 2 neutral)
A market-structure read based purely on real price and volume data — not full classic Wyckoff schematic identification (Phase A-E), but a quantitative analysis of what can reliably be computed: trading ranges, "effort vs. result", volume within the range, and Spring/Upthrust detection.
The stock is in a clear uptrend with no defined trading range in the period examined.
Medium confidence
The Wyckoff Method, developed by Richard Wyckoff in the early 20th century, reads the balance of supply and demand through price and volume, based on the premise that large investors ("smart money") quietly accumulate shares before rallies and quietly distribute them before declines. The read here is based solely on real price and volume data — full, precise identification of classic Wyckoff patterns (such as Phases A-E) requires human chart-reading experience and judgment, so this is an approximate algorithmic read, not a substitute for professional analysis. This should not be considered investment advice.
Gross Margin
88.2%
Operating Margin
67.7%
Net Margin
49.8%
EBITDA Margin
69.6%
ROE
-38.3%
ROA
62.3%
ROIC
—
EPS
—
Cash
$307.90M
Total Debt
—
Current Ratio
0.49
Debt/Equity
—
Total dividend per share paid each year, over the last 5 years.
| Ex-Dividend Date | Amount per Share |
|---|---|
| 19.8.2026 | $0.810 |
| 19.5.2026 | $0.810 |
| 18.5.2026 | $0.810 |
| 19.2.2026 | $0.810 |
| 18.2.2026 | $0.810 |
| 18.11.2025 | $0.770 |
| 17.11.2025 | $0.770 |
| 19.8.2025 | $0.770 |
| 18.8.2025 | $0.770 |
| 19.5.2025 | $0.770 |
| 18.5.2025 | $0.770 |
How is Fair Value calculated? →
Current Price
$298.46
Estimated Fair Value (DCF)
$190.79
Model estimate — not a price target. Highly sensitive to growth/discount-rate assumptions.
Gap
-36.1%
🔴 Appears expensive relative to estimated value
Year 1 Growth Rate
5.2%
Discount Rate (WACC)
9.0%
Terminal Growth Rate
2.5%
Projection Years
5
| Year | Growth Rate | Projected FCF | Present Value |
|---|---|---|---|
| 1 | 5.2% | $1.12B | $1.03B |
| 2 | 4.5% | $1.17B | $987.97M |
| 3 | 3.8% | $1.22B | $941.08M |
| 4 | 3.2% | $1.26B | $890.69M |
| 5 | 2.5% | $1.29B | $837.58M |
Base FCF (last actual year)
$1.07B
Terminal Value
$20.32B
Present Value of Terminal Value
$13.21B
Enterprise Value
$17.90B
Net Debt
$0
Equity Value
$17.90B
*The DCF model is an estimate based on assumptions — not a guaranteed forecast. You can change the assumptions to examine different scenarios.
Book Value per Share
-$22.97
Tangible Book Value per Share (Tangible NAV)
-$23.53
Sentiment based on basic keywords (not AI) — 14 positive, 6 neutral, 0 negative out of the last 20 articles.
Yahoo · 1.9.2026
MT Newswires · 1.9.2026
MT Newswires · 1.9.2026
Benzinga · 1.9.2026
Benzinga · 1.9.2026
Yahoo · 28.8.2026
ChartMill · 24.8.2026
ChartMill · 24.8.2026
Yahoo · 24.8.2026
Barchart · 24.8.2026
SeekingAlpha · 21.8.2026
MT Newswires · 19.8.2026
Yahoo · 17.8.2026
Zacks · 17.8.2026
SeekingAlpha · 14.8.2026
Yahoo · 14.8.2026
Zacks · 14.8.2026
Motley Fool · 13.8.2026
Yahoo · 13.8.2026
MT Newswires · 29.7.2026
Verisign (VRSN) currently has a StockIQ AI score of 65/100, rated "Moderate". The score is a weighted average across up to 7 categories (technical, fundamental, growth, fair value, news, quality, risk), based on real data only.
VRSN currently scores 65/100 (Moderate) across the categories we measure. StockIQ doesn't give buy/sell recommendations — use this as one data point in your own research, not as investment advice.
Per StockIQ's DCF model, VRSN's estimated fair value is $190.79, which is 36.1% below the current price of $298.46. This is one valuation model among several signals in the fair-value category, not a price target.
VRSN's technical score is 80/100, which currently reads as bullish — based on real price/volume signals (moving averages, RSI, MACD, and more), not a prediction of what happens next.
Based on the real signals StockIQ computed: Free cash flow growth: 22.2%; Operating margin is stable or improving over time; Price is above the 50-day average.
Based on the real signals StockIQ computed: Estimated fair value: $190.79 vs. price $298.46 (-36.1%); Current ratio: 0.49; Calmar: 0.46 (3y annualized return 14.4% / max drawdown 30.9%).
Yes — VRSN has a real recorded dividend payment history on StockIQ. See the Dividends section on this page for the actual per-share amounts and dates.
Real transactions by officers and insiders, as reported to the SEC on Form 4 — 4 purchases and 21 sales out of the last 25 filings.
| Name | Transaction Type | Date | Shares | Change | Price |
|---|---|---|---|---|---|
| BIDZOS D JAMES | Open Market Sale | 8.9.2026 | 900 | -900 | $282.03 |
| Indelicarto Thomas C | Open Market Sale | 8.9.2026 | 500 | -500 | $289.16 |
| BIDZOS D JAMES | Open Market Sale | 8.9.2026 | 300 | -300 | $279.66 |
| BIDZOS D JAMES | Open Market Sale | 8.9.2026 | 300 | -300 | $282.99 |
| BIDZOS D JAMES | Open Market Sale | 8.9.2026 | 1,000 | -1,000 | $289.16 |
| BIDZOS D JAMES | Open Market Sale | 8.9.2026 | 400 | -400 | $280.82 |
| BIDZOS D JAMES | Open Market Sale | 8.9.2026 | 100 | -100 | $287.04 |
| BIDZOS D JAMES | Open Market Sale | 8.9.2026 | 300 | -300 | $285.70 |
| BIDZOS D JAMES | Open Market Sale | 1.9.2026 | 100 | -100 | $295.91 |
| BIDZOS D JAMES | Open Market Sale | 1.9.2026 | 400 | -400 | $289.39 |
| BIDZOS D JAMES | Open Market Sale | 1.9.2026 | 1,900 | -1,900 | $290.90 |
| BIDZOS D JAMES | Open Market Sale | 1.9.2026 | 400 | -400 | $293.51 |
| BIDZOS D JAMES | Open Market Sale | 1.9.2026 | 300 | -300 | $291.60 |
| Indelicarto Thomas C | Open Market Sale | 1.9.2026 | 500 | -500 | $290.78 |
| BIDZOS D JAMES | Open Market Sale | 1.9.2026 | 200 | -200 | $288.30 |
| Armstrong Courtney D | Open Market Purchase | 27.8.2026 | 1,789 | +5 | $294.38 |
| Armstrong Courtney D | Open Market Purchase | 27.8.2026 | 5,232 | +14 | $293.44 |
| Armstrong Courtney D | Open Market Purchase | 27.8.2026 | 14.401 | +14.401 | $293.44 |
| Armstrong Courtney D | Open Market Purchase | 27.8.2026 | 4.91 | +4.91 | $294.38 |
| BIDZOS D JAMES | Open Market Sale | 25.8.2026 | 398,189 | -1,000 | $293.53 |
| BIDZOS D JAMES | Open Market Sale | 25.8.2026 | 399,689 | -1,700 | $289.28 |
| BIDZOS D JAMES | Open Market Sale | 25.8.2026 | 399,189 | -500 | $292.18 |
| BIDZOS D JAMES | Open Market Sale | 25.8.2026 | 398,089 | -100 | $294.22 |
| BIDZOS D JAMES | Open Market Sale | 25.8.2026 | 100 | -100 | $294.22 |
| BIDZOS D JAMES | Open Market Sale | 25.8.2026 | 1,000 | -1,000 | $293.53 |
Official FINRA data — the number of shares open in short positions, plus daily short-sale activity.
1,619,265 shares short as of 2026-08-31 · vs. 1,897,590 on 2026-07-31
Official biweekly report (FINRA Rule 4560) — no real higher-frequency data exists for this metric.
42.0% of trading volume this week was short selling, vs. 47.7% the prior week
Based on daily short-sale volume (Reg SHO) — a different metric from the open short interest above: this is daily trading volume, not an open position, so it updates weekly rather than biweekly.
Full breakdown of every data type and its source: Data Sources · Methodology